The CF Wind Sprint video series offers quick tips for living with CF. Topics include traveling, nutrition,exercise and treatments.
Every day, researchers around the world come one step closer to discovering a cure for cystic fibrosis. In the meantime, the CF drug “pipeline” ensures therapies are moving from the laboratory to the marketplace. We keep an eye on medical news sources from around the world and report on these developments as they occur.
2012
2011
2010

The Official Health and Wellness Partner of BEF

FDA Advisory Committee supports the use of Novartis inhalation powder, Tobramycin

09/06/2012

The FDA Advisory Committee voted 13 to 1 that research showed adequate evidence to support the use of tobramycin inhalation powder by cystic fibrosis patients whose lungs contain the bacteria Pseudomonas aeruginosa, the leading cause of lung function loss in patients with CF. Tobramycin inhalation powder (TIP) is intended for CF patients over the age of six whose lung function is within a specific range. Currently, TIP is approved in 38 countries.

To learn more about TIP, please see the Novartis Press Release.  

PREVIOUS
NEXT